Maxalt RPD 10 mg oralni liofilizati
| Name | Maxalt RPD 10 mg oralni liofilizati |
|---|---|
| Marketing Authorisation Number | HR-H-455098518 |
| Active Substance | rizatriptanbenzoat |
| Composition | jedan oralni liofilizat sadrži 14,53 mg rizatriptanbenzoata (što odgovara 10 mg rizatriptana). |
| Pharmaceutical Form | oralni liofilizat |
| Manufacturer | Merck Sharp & Dohme B.V., Haarlem, Nizozemska |
| Marketing Authorisation Holder | Organon Pharma d.o.o., Slavonska Avenija 1c, Zagreb, Hrvatska |
| Marketing Authorisation Date | 09.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/653 |
| Registration Number | 381-12-01/154-21-14 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N02CC04 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
